Inovio Pharma
(INO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,544 | 33,720 | 5,646 | 17,350 | 19,999 |
| Marketable Securities | 53,076 | 18,906 | 8,034 | 12,863 | 1,846 |
| Receivables | 2,804 | 3,302 | 867 | 506 | 105 |
| Income taxes - deferred | 343 | 62 | 63 | N/A | N/A |
| TOTAL | $98,947 | $58,684 | $15,968 | $31,907 | $22,877 |
| Non-Current Assets | |||||
| PPE Net | 4,583 | 2,887 | 363 | 296 | 277 |
| Investments And Advances | 12,891 | 10,483 | 11,071 | 9,272 | 11,361 |
| Intangibles | 14,890 | 15,832 | 17,603 | 19,424 | 21,293 |
| Other Non-Current Assets | 475 | 402 | 134 | 208 | 259 |
| TOTAL | $32,838 | $29,604 | $29,171 | $29,200 | $33,190 |
| Total Assets | $131,785 | $88,287 | $45,139 | $61,107 | $56,067 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,412 | 5,967 | 3,369 | 4,339 | 5,092 |
| Accrued Expenses | 2,007 | 1,446 | 1,406 | 1,059 | 178 |
| Other current liabilities | 2,023 | 19,541 | 2,860 | 5,176 | 371 |
| TOTAL | $14,085 | $28,967 | $8,377 | $11,043 | $6,437 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,644 | 2,013 | 742 | 468 | 796 |
| Other Non-Current Liabilities | 18 | 55 | 44 | 51 | 25 |
| TOTAL | $6,162 | $6,418 | $1,905 | $2,202 | $2,530 |
| Total Liabilities | $20,248 | $35,385 | $10,281 | $13,245 | $8,967 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,060 | 4,990 | 3,747 | 2,811 | 2,650 |
| Common Shares | 61 | 53 | 144 | 135 | 105 |
| Retained earnings | -331,910 | -295,789 | -229,760 | -210,091 | -194,838 |
| Other shareholders' equity | 59 | 371 | 576 | 582 | 601 |
| TOTAL | $111,538 | $52,903 | $34,857 | $47,862 | $47,101 |
| Total Liabilities And Equity | $131,785 | $88,287 | $45,139 | $61,107 | $56,067 |